[A trial of using a dry bifidobacterin preparation with newborn risk groups to prevent acute intestinal infections].
The dried preparation of bifidumbacterin was administered to newborn infant during 4-6 days of their stay in a maternity clinic. The test group consisted of 110 infants and the control group, of 115 infants. Bacteriological studies indicated that the administration of bifidumbacterin produced a positive effect on the formation of the intestinal microflora in infants. During the first 3 months of life the registered cases of acute enteric infections among the children of the test group were 3 times less frequent than among the children of the control group. A perceptible prophylactic effect produced by this preparation with respect to purulent septic infections of the skin and the buccal mucosa was also noted.
N A
NA
Chernysheva
K I
KI
Mel'nikova
M P
MP
Finkel'
Z B
ZB
Izotova
D000208:Acute Disease; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000453:epidemiology / Q000517:prevention & control*; D001688:Biological Products / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D007410:Intestinal Diseases / Q000453:epidemiology / Q000517:prevention & control*; D007422:Intestines / Q000382:microbiology; D012307:Risk Factors; D012871:Skin Diseases / Q000453:epidemiology / Q000517:prevention & control; D013997:Time Factors
D000890:Anti-Infective Agents; D001688:Biological Products; C010546:bifidobacterin
Opyt primenenia preparata sukhogo bifidumbakterina novorozhdennym grupp riska s tsel'iu profilaktiki ostrykh kishechnykh infektsiĭ.